Vitamin D in the Healthy Paediatric Population: A Position Paper by the ESPGHAN Committee on Nutrition

*Division of Gastroenterology and Nutrition, University Children's Hospital Zurich, Zurich, Switzerland †Department of Pediatrics, University of Granada, Spain ‡Hospital Necker, Paris, France §Department of Paediatrics, University of Pecs, Hungary ||Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden ¶MRC Childhood Nutrition Research Centre, UCL Institute of Child Health, London, UK #Children's Hospital Zagreb, Zagreb, Croatia **Department of Paediatrics, Deaconry Hospital, Schwaebisch Hall, Germany ††Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Frederiksberg C, Denmark ‡‡Schneider Children's Medical Center of Israel, Sackler Faculty of Medicine, Tel-Aviv University, Israel §§Jeanne de Flandre Children's Hospital, Lille University Faculty of Medicine, France ||||Pediatrics, VU University Medical Center Amsterdam Netherlands and Pediatrics, Emma Children's Hospital-AMC, Amsterdam, the Netherlands. 1Committee Secretary. 2Committee Chair.
Journal of pediatric gastroenterology and nutrition (Impact Factor: 2.87). 03/2013; 56. DOI: 10.1097/MPG.0b013e31828f3c05
Source: PubMed

ABSTRACT In recent years, reports suggesting a resurgence of vitamin D deficiency in the Western world, combined with various proposed health benefits for vitamin D supplementation have resulted in increased interest from healthcare professionals, the media and the public. The aim of this position paper is to summarize the published data on vitamin D intake and prevalence of vitamin D deficiency in the healthy European paediatric population, to discuss health benefits of vitamin D and to provide recommendations for the prevention of vitamin D deficiency in this population. Vitamin D plays a key role in calcium and phosphate metabolism and is essential for bone health. There is insufficient evidence from interventional studies to support vitamin D supplementation for other health benefits in infants, children and adolescents. The pragmatic use of a serum concentration above 50 nmol/l to indicate sufficiency and a serum concentration below 25 nmol/l to indicate severe deficiency is recommended. Vitamin D deficiency occurs quite commonly among healthy European infants, children and adolescents, especially in certain risk groups including breast-fed infants not adhering to the current recommendation for vitamin D supplementation, children and adolescents with dark skin living in Northern countries, as well as children and adolescents without adequate sun exposure, and obese children. Infants should receive an oral supplementation of 400 IU/day of vitamin D. The implementation should be promoted and supervised by paediatricians and other healthcare professionals. Healthy children and adolescents should be encouraged to follow a healthy lifestyle associated with a normal body mass index and including a varied diet with vitamin D containing foods (fish, eggs, dairy products) and adequate outdoor activities with associated sun exposure. For children in risk groups identified above an oral supplementation of vitamin D must be considered beyond one year of age. National Authorities should adopt policies aimed at improving vitamin D status using measures such as dietary recommendations, food fortification, vitamin D supplementation and judicious sun exposure, depending on local circumstances.

Download full-text


Available from: Iva Hojsak, Aug 20, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Clostridium difficile is recognized as a frequent cause of antibiotic-induced diarrhea. This study was designed to investigate whether Clostridium difficile toxin A might induce apoptosis on human hepatoma cell line SMMC7721 and African green monkey kidney Vero cells. Highly purified toxin A was obtained by bovine thyroglobulin affinity purification followed by ion exchange chromatography on Q sepharose. The apoptosis induction of toxin A was examined on SMMC7721 cells with Vero cells as a control. Inhibition of proliferation was measured by MTT assay. Morphological assessment of apoptosis was performed with fluorescence and electronic microscopy. DNA fragmentation was observed by agarose gel electrophoresis. Cell cycle distribution was analyzed by flow cytometry. Toxin A (0.293-4.690 mg x L(-1) ) inhibited proliferation of SMMC7721 and Vero cells in a time- and concentration-dependent manner. Morphological changes of typical apoptosis showed that SMMC7721 had a higher percentage of apoptosis than Vero cells. Agarose gel electrophoresis of DNA from SMMC7721 treated with toxin A for 48 hours revealed a "ladder" pattern. Clostridium difficile toxin A induced apoptosis of SMMC7721 and Vero cells. The apoptosis induction on SMMC7721 cells was more effective than that on Vero cells.
    Ai zheng = Aizheng = Chinese journal of cancer 08/2003; 22(7):719-24.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vitamin D plays an important role in human health. Current recommendations for vitamin D intake and endogenous supply through sun exposure are not met in German pre-school children, and suboptimal serum 25-hydroxyvitamin D concentrations, especially during the winter months, are common. Consequently, vitamin D supplementation or fortification have gained increased acceptance. The KiMi trial (Kindermilch = growing up milk) was a prospective, randomized, and double-blind study in which young children (2-6 years of age, n = 92) were assigned to receive either vitamin D-fortified growing up milk (2.85 μg/100 ml) or semi skimmed cow's milk without added vitamin D. Daily consumption of fortified growing up milk contributed to the prevention of an otherwise frequently observed decrease in serum 25-hydroxyvitamin D concentration during winter (before winter: median 21.5 ng/mL (10.1-43.0 ng/mL) intervention vs. median 18.4 ng/mL (11.0-44.9 ng/mL) control; after winter: median 24.8 ng/mL (7.0-48.2 ng/mL) intervention vs. median 13.6 ng/mL (7.0-36.8 ng/mL) control) and proved to be safe during summer (median 27.6 ng/mL (18.8-40.5 ng/mL) intervention vs. median 27.4 ng/mL (17.8-38.7 ng/mL) control). Due to the high prevalence of vitamin D deficiency, fortification of growing up milk with vitamin D at a level used in this study could be an effective measure to improve vitamin D status.
    European Journal of Pediatrics 07/2013; 172(12). DOI:10.1007/s00431-013-2092-6 · 1.98 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Vitamin D is critical to bone mineral metabolism and to the growth and development of the skeleton. Optimizing vitamin D status could be one of the cornerstones to optimize skeletal growth and achieving the maximum peak bone mass soon after the completion of adolescence. Maximizing peak bone mass is considered to be the key to primary prevention of osteoporosis. There is controversy, however, about what constitutes a healthy vitamin D status based on the most abundant circulating metabolite of vitamin D, namely 25 hydroxyvitamin D (25 OHD) in plasma or serum; and even the value of 25 OHD that should be used to define vitamin D deficiency. We reviewed the recent data on circulating 25 OHD concentrations and its relationship with skeletal growth in apparently healthy children and in those with nutritional vitamin D deficiency.
    Current Osteoporosis Reports 07/2013; 11(3). DOI:10.1007/s11914-013-0156-1
Show more